The spirochete Borrelia burgdorferi is the causative agent of Lyme borreliosis (19) , a multisystem disorder characterized by an initial skin lesion (erythema migrans) present in about 50% of those with the disease. In addition, neurological and cardiac manifestations may follow weeks to months later. If not treated, the infection may recur as chronic encephalomyelitis, chronic arthritis, and, in Europe, acrodermatitis chronica athrophicans (40) . B . burgdorferi has been isolated from different biological materials, including skin and cerebrospinal fluid (CSF) of humans, wild and domestic animals, and ixodid ticks from different geographic areas (North America, Europe, and Asia) (for reviews, see references 2 and 41).
Considerable antigenic heterogeneity has been observed among B. burgdorferi isolates from Europe (7-9, 45, 47) . Isolates from North America appeared to be more homogeneous except for variants described by Anderson et al., which have been predominantly isolated from Lxodes dentatus (3, 4) . North American strains usually express two abundant outer surface proteins, OspA and OspB, of 31 and 34 kDa, respectively (9, 11) . The Osp proteins of the European isolates are heterogeneous in size, and these strains often (about 40% of the strains) express an additional abundant protein of about 22 kDa which was designated pC (45, 47) . Some North American B. burgdorferi strains expressing a major protein of about 20 kDa have been described (4, 14, 29, 30 Very recently, Brown and Lane (16) reported that about one-third of 91 strains isolated from Californian ticks and wild animals express a major ca. 20-kDa protein which could be analogous to the pC protein expressed by European isolates. Despite the lesser abundance of pC than of OspA in cells in culture, pC elicits an intense and early humoral immune response in patients with Lyme borreliosis (46, 47) . Antibodies to OspA are only rarely observed and appear, if ever, only late during disease (6, 44, 46, 47) . The pC protein was recently cloned by our group (23) . Sequence analysis revealed a leader peptide-encoding sequence, indicating processing of pC similar to that of lipoproteins (as previously shown for OspA and OspB, two other outer surface proteins of B. burgdorferi [13] ).
In this article we give conclusive data that pC is a major outer membrane protein of B. burgdorferi, as revealed by immunoelectron microscopy with a monoclonal antibody (MAb). The protein is therefore renamed outer surface proteinC (OspC), by analogy to OspA and OspB. Like OspA (21, 37 ), OspC appears to be a major candidate for a Borrelia vaccine (33) .
Consequently, it was considered important with regard to vaccines and diagnostic assays to determine the immunological and genetic heterogeneity of OspC, especially in relation to the OspA serotype (41, 47a) and genomic groups of B. burgdorferi (1, 5) . In the present study, 45 B. burgdorferi isolates that expressed a major OspC and three strains that did not were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblot with polyclonal and monoclonal antibodies against OspC.
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OspC-expressing variants of nonexpressing isolates were also obtained by cultivation of the spirochetes on solid medium. Furthermore, we were able to amplify the ospC gene by polymerase chain reaction (PCR) from nonexpressing strains. The ospC gene of one of these strains was cloned and expressed in Escherichia coli. Thus, it was possible to characterize the OspCs not only of expressing strains but also of nonexpressing strains.
MATERIALS AND METHODS
Borrelia strains and culture. The designations and origins of the B. burgdorfeni strains investigated in this study are given in Table 1 . The strains were analyzed for their OspA serotype by using a panel of eight MAbs as described previously (41, 47a) . Culture was performed in modified Kelly medium (MKP) as described before (35) . OspC-expressing clones (Table 1) were obtained from a nonexpressing isolate (strain PKa2) by culture on solid agar for 3 weeks (34) . Randomly selected colonies were grown on liquid medium (MKP) for further immunochemical analysis. Two other OspC-negative strains (Ixodes dammini isolate B31
[ATCC 35210] [19] and German CSF isolate PBr [45] ) and B. hermsii HS1 serotype C (ATCC 35209) (10) were also included in the study.
Immunoelectron microscopy. Cultures of strain PKo in late log phase were washed three times in phosphate-buffered saline (PBS)-Mg by the method of Barbour et al. (11) . The cells from half the sample were fixed with 0.5% glutaraldehyde for 30 min at 22°C and with methanol for 3 min at 4°C; the cells from the other half of the sample were left unfixed. Both specimens were incubated with MAb L22 1F8 or MAb L41 lCll for 2 h at 22°C. Cells were washed three times in PBS-Mg and reacted for 3 h with gold-labeled anti-mouse immunoglobulin conjugate (auroprobe EM GAM; immunoglobulin G [IgG] plus IgM; particle size, 10 nm; Amersham Buchler GmbH, Braunschweig, Germany). After three washings in PBS-Mg, the spirochetes were fixed with 2.5% glutaraldehyde in 75 mM sodium cacodylate-1 mM MgCl2 (pH 7.2). After extensive rinsing with the same buffer, the cells were postfixed for 30 min in 1% osmium tetroxide in buffer. For en bloc staining, the cells were incubated with 1% uranyl acetate in 20% acetone for 30 min. Dehydration was performed with a graded series of acetone solutions. Cells were finally infiltrated and embedded in Spurr's lowviscosity resin, polymerized, cut with a diamond knife on a Reichert-Jung Ultracut E ultramicrotome, and mounted on uncoated copper grids. The sections were poststained with aqueous lead citrate (3%, pH 13). All burgdorfen B31, PKa2, PWudI, PBr, PBi, TN, and T25, and the ospC genes were amplified from genomic DNA by PCR as described for amplification of the ospA gene (48) . Cloning of the PCR products and sequencing were performed by standard protocols (23, 48) . Nucleotide sequence accession numbers. The ospC sequence data for strains PKa2, PWudI, T25, TN, PBr, PBi, and B31 will appear in the EMBL/GenBank/DDBJ nucleotide sequence data libraries under accession numbers X69589, X69590, X69592, X69593, X69594, X69595, and X69596, respectively.
RESULTS
Demonstration of the surface location of OspC by immunoelectron microscopy. Electron microscopic investigation of ultrathin sections of B. burgdorferi PKo labeled with MAb L22 1F8 shows that OspC is an outer surface protein (Fig. 1) . The high density of the immunogold labeling, which is best seen in tangential section (Fig. 1A , arrowheads), documents that OspC is abundantly expressed on the outer surface and (as shown in Fig. 1B ) is associated exclusively with the outer membrane. Some B. burgdorferi cells show disruption of the outer membrane. Despite the fact that the periplasmic space was accessible for antibody reaction, the immunogold-labeled antibody did not bind to flagella (Fig. 1A, arrows) or to the inner membrane (Fig. 1B) . In contrast, in the control preparation, the flagellum-specific MAb IA1 lCll did not react with the outer membrane and bound only to the flagella (Fig. 1C) Partial sequencing of the ospC genes from different strains reveals OspC polymorphisms. The ospC genes were amplified from the DNAs of strains B31, PKa2, PWudI, PBr, PBi, TN, and T25, and the amplification products were cloned in pUC8. The plasmids were designated pUC8-B31/ospCL+, pUC8-PKa2/ospCL+, pUC8-PWudI/ospCL+, pUC8-PBr/ ospCL+, pUC8-PBi/ospCL+, pUC8-TN/ospCL+, and pUC8-T25/ospCL+, respectively. In the case of B31, an ospC amplification product lacking coding sequence for the leader peptide was also cloned in pUC8 (pUC8-B31/ospCL-). Three of the strains investigated (B31, PKa2, and PBr) do not express OspC. Despite the fact that ospC is not expressed in strain B31 (Fig. 3b, lanes 3 ), we were able to express the ospC gene in E. coli (Fig. 3a) . Deletion of the leader sequence prior to cloning apparently led to particularly high expression of the B31-derived OspC protein in E. coli (Fig. 3a) . This had been observed for the cloned ospC gene of strain PKo as well. The full sequences of the ospC genes of strains B31 and PBi will be published elsewhere (26a) .
The ospC genes had conserved 3' and 5' ends and were more variable in the internal part of the sequence. Sequence comparison of the 240 3'-terminal nucleotides of the ospC genes from the eight strains revealed considerable molecular variability of ospC (Fig. 4 and Table 2 ). This analysis showed that with the exception of the two B. garinii strains PBr and TN, which were OspA serotypes 3 (Fig. 3c) .
With the three MAbs, four different reactivity patterns were observed among the B. burgdorferi strains tested, which are designated a, b, c, and d in Fig. 5 and  6 ). The immunological OspC variants of a given OspA serotype differed in size; examples are shown in Fig. 5 and 6 . We found that strains that did not express OspA also varied in the epitopes of their OspC proteins (Fig. 7) . In contrast, five strains of OspA serotype 4 were identical in their OspC MAb patterns (Fig. 6 ). For OspA serotypes 5 and 7, only one OspC-expressing strain was available. The OspCs of these two strains could not be distinguished by MAbs, either from each other or from the OspCs of the majority of OspA serotype 6 strains (Fig. 6) (45, 47) and therefore might be identical to OspC. However, Brown and Lane showed that Californian strains may express more than one major ca. 20-kDa protein (16) . Other minor proteins of about 20 kDa, some of which are especially reactive with immune sera against unrelated bacteria, can be mistaken for OspC in diagnostic Western blots (17) . This is an indication that, for proper serodiagnosis, further investigations are necessary to delineate the different forms of 20-kDa-range proteins of B.
burgdorferi. (23) burgdorferi may be homologous to the VMPC of B. henmsii. However, molecular analysis of VMPC is necessary to prove this hypothesis. As described by Barbour et al. (10) and Barstad et al. (12) , the relapsing-fever strain B. herrnsii is characterized by alternating expression of outer surface proteins (VMPs). Therefore, it appears promising to investigate whether B. burgdorferi uses strategies of antigenic variation similar to those of B. hermsii.
Molecular analysis of OspC revealed that OspC
OspC is, besides the flagellin protein, the immunodominant antigen of the early immune response in patients with Lyme borreliosis (25, 28, 46, 47) . This was first recognized in European patients. Recently, however, Dressler et al. (20) also detected an OspC-specific immune response in American patients with erythema migrans by using an OspCexpressing variant of an American tick isolate as the antigen. This was confirmed in our laboratory by using recombinant OspC as the antigen (unpublished results).
Whereas patients with Lyme borreliosis show a good immune response against OspC, the immune response against OspA is rather weak. In contrast to this finding is the observation that more than 90% of B. burgdorferi culture isolates express OspA but only 40% express OspC (6, 46, 47) . This may indicate that, in vivo, OspA expression is low CB PKa2 clones PKa2 1 5 9 13 17 (32) and OspC expression is high. Evidence of this is the finding of Schwan et al. (38) that during infection of mice with a B. burgdorferi strain that does not express a major ca. 20-kDa protein in vitro, the immune response shifted from a major OspA-specific response to a response against a 24-kDa protein. Other in vitro and in vivo studies have also confirmed variation of OspA versus OspC expression in B. burgdorfen. Such variations occurred among the progeny of individual isolates (45, 47) .
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